Upon successful completion of the subject student shall be able to: KNOWLEDGE
K1: Explain the various unit processes in process chemistry.
K2: Demonstrate the fermentation process, involving Aerobic and Anaerobic.
K3: Assess the effectiveness and efficiency of different unit operations in process chemistry through case studies
K4: Optimize reaction progress kinetic analysis by streamlining reaction steps
K5: Evaluate the case studies based on unit processes, and scale up the product.
K6: Design a comprehensive industrial safety protocol for a chemical process, incorporating advanced safety measures and risk assessment techniques.
SKILL
S1: Acquire the ability to scale up chemical processes for the synthesis and manufacturing of pharmaceutical compounds.
S2: Determine the purity of the Organic compounds/APIs by physical and spectroscopy.
S3: Compare the different synthetic mechanisms of active pharmaceutical ingredients.
S4: Assess the challenges related to scale-up, ensuring efficiency and safety in industrial settings
S5: Ensure compliance with regulatory requirements and quality standards in pharmaceutical process development.
S6: Develop proficiency in analytical techniques such as chromatography, spectroscopy, and mass spectrometry for process monitoring and control.
ATTITUDE
A1: Collaborate with teams focused on the development and optimization of pharmaceutical compounds.
A2: Elevate critical thinking skills specifically relevant to the analysis and synthesis of information in the domain of process chemistry.
A3: Develop the ability to critically evaluate and optimize chemical processes for pharmaceutical production.
A4: Foster a commitment to lifelong learning with a specific emphasis on advancements and innovations in process chemistry within the pharmaceutical industry.
A5: Exhibit intrinsic motivation to engage in self-directed learning activities pertinent to process chemistry principles and applications.
A6: Display a proactive approach to problem-solving, specifically in the realm of process chemistry, by addressing challenges encountered in pharmaceutical production.